MediTrust Health Shares Insights at Hong Kong Fintech Week: AI Pragmatically Reshaping Cross-Border Healthcare Payments in the Greater Bay Area
HONG KONG, Nov. 6, 2025 /PRNewswire/ -- MediTrust Health, the largest innovative healthcare payor platform in China, delivered key insights recently at the HealthTech Forum of "Hong Kong FinTech Week 2025." Seth Zhang, Founder and CEO of MediTrust Health, stated that Artificial Intelligence (AI) is bringing disruptive innovation to the traditional insurance sector, with cross-border services emerging as a new...
Alphamab Oncology Showcases Cutting-edge Breakthroughs and Innovative Achievements at the 16th World ADC San Diego
SUZHOU, China, Nov. 6, 2025 /PRNewswire/ -- The 16th World ADC San Diego, held from November 3–6, 2025, brought together industry leaders in San Diego, USA. Dr. Ting Xu, Founder, Chairman, and CEO of Alphamab Oncology, was invited to deliver a presentation titled "JSKN021: EGFR/HER3 Targeted Dual-payload ADC", showcasing the company's cutting-edge technological breakthroughs and innovative achievements in the ADC...
The 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) will be held in Kunming, presenting a new landscape of integrated cancer prevention and treatment from a global perspective.
KUNMING, China, Nov. 6, 2025 /PRNewswire/ -- From November 6 to 9, 2025, the highly anticipated 2025 CCHIO will be grandly held in Kunming, the "Spring City". Hosted by the Chinese Anti-Cancer Association and the Secretariat of the Tengchong Scientists Forum Organizing Committee, co-hosted by the World Association of Integrative Oncology (WAIO) and the China Institute of Integrative Medicine Development...
New Regional Certifications to Boost Healthcare Training Standards Across Southeast Asia
Two new specially designed certification programmes will train doctors, nurses and technical specialists across the region in simulation-based medical education. SINGAPORE, Nov. 6, 2025 /PRNewswire/ -- The first healthcare simulation certification programmes designed specifically for Southeast Asian professionals were launched at the S3 Conference 2025 opening ceremony today. The event...
The World’s First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia
CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and Significant Efficacy SHANGHAI, Nov. 6, 2025 /PRNewswire/ -- On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology company pioneering transformer Base Editing (tBE) technology for the treatment of severe diseases, announced that the first patient in its Investigator-Initiated Trial (IIT) of the base-editing therapy CS-121 targeting APOC3 for chylomicronemia / hypertriglyceridemia has successfully...
Natural Field will Launch “Ashwagandha White Paper” at FTA Forum in Hangzhou
HANGZHOU, China, Nov. 5, 2025 /PRNewswire/ -- Natural Field, a leading Chinese supplier of botanical and functional ingredients, is set to release its highly anticipated Ashwagandha White Paper at the prestigious Food Technology and Application (FTA) Forum in Hangzhou. The forum, recognized as one of China's foremost platforms for nutrition and health innovation, brings together leading researchers, industry professionals,...
Andor Health’s Agentic AI Platform, ThinkAndor®, Receives Frost & Sullivan’s 2025 North American Transformational Innovation Leadership Recognition for Excellence in Acute Care Virtual Health
Recognized for its transformational innovation and customer impact in driving the evolution of acute care virtual health through advanced, agentic AI-powered collaboration solutions. SAN ANTONIO, Nov. 5, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Andor Health has received the 2025 North American Transformational Innovation Leadership Recognition in the acute care virtual health industry for its outstanding achievements...
Milliken & Company Recognized with 2025 EcoVadis Gold Rating, Placing in Top 5% Worldwide
SPARTANBURG, S.C., Nov. 5, 2025 /PRNewswire/ -- Milliken & Company, a global leader in manufacturing and material science, has earned a gold rating in the 2025 EcoVadis assessment for the fourth consecutive year, placing the company among the top 5% of more than 150,000 organizations evaluated around the world. This achievement marks...
IDT Biologika Accelerates Global CDMO Expansion Manufacturing capabilities highlighted through consecutive participation in WVC, CPHI and BIO-Europe 2025
Showcased end-to-end, customized manufacturing capabilities covering vaccines, gene and immune therapeutics Strengthening global CDMO strategy through strategic synergy with SK bioscience Sustainable growth expected, backed by European commercial manufacturing infrastructure and regulatory expertise FRANKFURT, Germany, VIENNA and SEONGNAM, South Korea, Nov. 5, 2025 /PRNewswire/ -- IDT Biologika GmbH (IDT), the...
BioDlink Congratulates Lepu Biopharma on Securing Approval for the World’s First Approved EGFR-Targeted ADC
BioDlink helps Lepu Biopharma win China's marketing approval for EGFR-targeted ADC treating recurrent or metastatic nasopharyngeal carcinoma This Becotatug Vedotin injection approval is BioDlink's first commercial ADC manufacturing initiative worldwide, validating its complex biologics commercialization capabilities SUZHOU, China, Nov. 5, 2025 /PRNewswire/ -- BioDlink (1875.HK) congratulates its partner Lepu Biopharma...
